JP7377526B2 - Skin cosmetic composition - Google Patents
Skin cosmetic composition Download PDFInfo
- Publication number
- JP7377526B2 JP7377526B2 JP2019236476A JP2019236476A JP7377526B2 JP 7377526 B2 JP7377526 B2 JP 7377526B2 JP 2019236476 A JP2019236476 A JP 2019236476A JP 2019236476 A JP2019236476 A JP 2019236476A JP 7377526 B2 JP7377526 B2 JP 7377526B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- component
- mass
- present
- moist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 31
- 239000000203 mixture Substances 0.000 title claims description 29
- 241000218492 Lactobacillus crispatus Species 0.000 claims description 12
- 241000194032 Enterococcus faecalis Species 0.000 claims description 11
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 11
- LZVDTTZUUGMGNY-JWOPXBRZSA-N (2s)-5-(diaminomethylideneamino)-2-(2,3-dihydroxypropylamino)pentanoic acid;hydrochloride Chemical compound Cl.NC(N)=NCCC[C@@H](C(O)=O)NCC(O)CO LZVDTTZUUGMGNY-JWOPXBRZSA-N 0.000 claims description 8
- SAVLIIGUQOSOEP-UHFFFAOYSA-N N-octanoylglycine Chemical compound CCCCCCCC(=O)NCC(O)=O SAVLIIGUQOSOEP-UHFFFAOYSA-N 0.000 claims description 8
- 229940051368 capryloyl glycine Drugs 0.000 claims description 7
- 238000011156 evaluation Methods 0.000 description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 11
- 241000186660 Lactobacillus Species 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 229940039696 lactobacillus Drugs 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000194033 Enterococcus Species 0.000 description 6
- -1 Polyoxyethylene Polymers 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 230000005923 long-lasting effect Effects 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 150000003862 amino acid derivatives Chemical class 0.000 description 4
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 4
- 108010045569 atelocollagen Proteins 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 229940124274 edetate disodium Drugs 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229960003121 arginine Drugs 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 241000194031 Enterococcus faecium Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 150000001483 arginine derivatives Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 150000002332 glycine derivatives Chemical class 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- SUUWYOYAXFUOLX-ZBRNBAAYSA-N (2s)-2-aminobutanedioic acid;(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CCCN=C(N)N SUUWYOYAXFUOLX-ZBRNBAAYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- FDKNTODVCFVEDJ-UHFFFAOYSA-N 2-[3-(dodecylamino)propylamino]acetic acid Chemical compound CCCCCCCCCCCCNCCCNCC(O)=O FDKNTODVCFVEDJ-UHFFFAOYSA-N 0.000 description 1
- AROIQOVITQZEIR-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-(dodecanoylamino)acetic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)NCC(O)=O AROIQOVITQZEIR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- SVBBTCUNQJOQAA-UHFFFAOYSA-N 3-ethyl-2-oxopyrrolidine-1-carboxylic acid Chemical compound CCC1CCN(C(O)=O)C1=O SVBBTCUNQJOQAA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- RVEWUBJVAHOGKA-WOYAITHZSA-N Arginine glutamate Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RVEWUBJVAHOGKA-WOYAITHZSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241001468179 Enterococcus avium Species 0.000 description 1
- 241001522957 Enterococcus casseliflavus Species 0.000 description 1
- 241000194030 Enterococcus gallinarum Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000272185 Falco Species 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- SNEIUMQYRCDYCH-UHFFFAOYSA-N acetylarginine Chemical compound CC(=O)NC(C(O)=O)CCCN=C(N)N SNEIUMQYRCDYCH-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229960002223 arginine aspartate Drugs 0.000 description 1
- 229960004246 arginine glutamate Drugs 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WSWYZRBSUBMICN-UHFFFAOYSA-N azanium;2-(dimethylamino)-3-oxopent-4-ene-1-sulfonate Chemical compound [NH4+].[O-]S(=O)(=O)CC(N(C)C)C(=O)C=C WSWYZRBSUBMICN-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 229940096989 lauryl aminopropylglycine Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は皮膚化粧料組成物に関し、特に、皮膚に対してしっとり感およびもっちり感を付与し、しっとり感の持続性が良好な皮膚化粧料組成物に関する。 The present invention relates to a skin cosmetic composition, and particularly to a skin cosmetic composition that imparts a moist and elastic feel to the skin and has a good long-lasting moist feeling.
従来、皮膚化粧料組成物は乾燥や肌あれ等の皮膚状態を改善することが求められている。乾燥や肌あれ等を改善する成分として、多価アルコールや植物油等が用いられてきた。 Conventionally, skin cosmetic compositions have been required to improve skin conditions such as dryness and rough skin. Polyhydric alcohols, vegetable oils, etc. have been used as ingredients to improve dryness and rough skin.
近年では消費者の安全と健康に対する意識の向上から、人体内に存在しており、有益な役割を果たす乳酸菌が注目されている。乳酸菌は整腸作用や免疫増強を有する安全な素材として知られており、乳酸菌を多量に含むヨーグルトや飲料が、健康と美容に良いとして消費者に広く支持されている。最近では、これらの乳酸菌は皮膚状態の改善を目的にした化粧料原料としても用いられている。 In recent years, as consumers' awareness of safety and health has increased, lactic acid bacteria, which exist in the human body and play a beneficial role, have attracted attention. Lactic acid bacteria are known as safe materials with intestinal regulating effects and immune enhancement, and yogurts and drinks containing large amounts of lactic acid bacteria are widely supported by consumers as being good for health and beauty. Recently, these lactic acid bacteria have also been used as raw materials for cosmetics aimed at improving skin conditions.
特許文献1では、エンテロコッカス属(Enterococcus)乳酸球菌の加熱処理死菌体を含有することを特徴とする化粧料組成物を皮膚に塗布することで、皮膚のしっとり感ともっちり感が改善することを開示している。 Patent Document 1 discloses that applying a cosmetic composition containing heat-treated killed bacteria of Enterococcus lactic acid bacteria to the skin improves the moist feel and firmness of the skin. Disclosed.
特許文献2では、酵素で処理したラクトバチルス・クリスパタス(Lactobacillus Crispatus)の培養物を含有することを特徴とする化粧料組成物を皮膚に塗布することで皮膚の保湿効果が高まることを開示している。 Patent Document 2 discloses that the skin moisturizing effect is enhanced by applying a cosmetic composition containing an enzyme-treated culture of Lactobacillus Crispatus to the skin. There is.
皮膚化粧料組成物は皮膚に塗布することで皮膚状態を改善することに加え、その効果が持続することが求められている。 Skin cosmetic compositions are required not only to improve the skin condition when applied to the skin, but also to maintain their effects.
しかしながら、特許文献1および特許文献2に記載の化粧料組成物は皮膚にしっとり感やもっちり感を付与するものの、その効果は一過性であり、特にしっとり感の持続性は不十分であった。 However, although the cosmetic compositions described in Patent Document 1 and Patent Document 2 impart a moist and firm feel to the skin, the effect is temporary, and in particular, the sustainability of the moist feeling is insufficient. Ta.
本発明は、皮膚に対してしっとり感およびもっちり感を付与し、しっとり感の持続性が良好な皮膚化粧料組成物を提供することを課題とする。 An object of the present invention is to provide a skin cosmetic composition that imparts a moist and elastic feel to the skin and has a good long-lasting moist feeling.
本発明者は、(A)エンテロコッカス属(Enterococcus)乳酸球菌および(B)ラクトバチルス属(Lactobacillus)乳酸桿菌から選ばれる1種以上、(C)アミノ酸誘導体から選ばれる1種以上を含有し、前記(C)成分の含有量が0.002~1質量%である皮膚化粧料組成物に皮膚に対してしっとり感およびもっちり感を付与し、しっとり感の持続性が良好な皮膚化粧料組成物が得られることを見出し、本発明を完成するに至った。 The present inventor has proposed a method containing at least one species selected from (A) Lactobacillus of the genus Enterococcus and (B) Lactobacillus of the genus Lactobacillus, and (C) one or more species selected from amino acid derivatives; A skin cosmetic composition that imparts a moist and elastic feel to the skin and has a good long-lasting moist feeling, with the content of component (C) being 0.002 to 1% by mass. The present inventors have discovered that the following can be obtained, and have completed the present invention.
本発明により、皮膚に対してしっとり感およびもっちり感を付与し、しっとり感の持続性が良好な皮膚化粧料組成物が得られた。 ADVANTAGE OF THE INVENTION According to the present invention, a skin cosmetic composition that imparts a moist and elastic feel to the skin and has a good long-lasting moist feeling has been obtained.
以下、本発明を詳細に説明する。 The present invention will be explained in detail below.
本発明は、(A)エンテロコッカス属(Enterococcus)乳酸球菌および(B)ラクトバチルス属(Lactobacillus)乳酸桿菌から選ばれる1種以上、(C)アミノ酸誘導体から選ばれる1種以上を含有し、前記(C)成分の含有量が0.002~1質量%である皮膚化粧料組成物である。 The present invention contains at least one species selected from (A) Lactobacillus of the genus Enterococcus and (B) Lactobacillus of the genus Lactobacillus, and (C) one or more species selected from amino acid derivatives, and (C) at least one species selected from amino acid derivatives; A skin cosmetic composition in which the content of component C) is 0.002 to 1% by mass.
本発明はしっとり感およびしっとり感の持続性を付与する観点から(A)エンテロコッカス属(Enterococcus)乳酸球菌を含有する。 The present invention contains (A) lactic acid cocci of the genus Enterococcus from the viewpoint of imparting a moist feeling and the sustainability of the moist feeling.
本発明の前記(A)成分はエンテロコッカス属(Enterococcus)乳酸球菌の死菌体である。 The component (A) of the present invention is a killed bacterial cell of lactic acid coccus of the genus Enterococcus.
本発明で用いられる前記(A)成分としては、特に限定されないが、例えば、エンテロコッカス・フェカリス(Enterococcus faecalis)、エンテロコッカス・フェシウム(Enterococcus faecium)、エンテロコッカス・アビウム(Enterococcus avium)、エンテロコッカス・ガリナルム(Enterococcus gallinarum)、エンテロコッカス・カセリフラブス(Enterococcus casseliflavus)等が挙げられ、前記(A)成分は1種以上を含有してよい。 The component (A) used in the present invention is not particularly limited, but includes, for example, Enterococcus faecalis, Enterococcus faecium, Enterococcus avium, and Enterococcus gallium. Enterococcus gallinarum ), Enterococcus casseliflavus, etc., and the component (A) may contain one or more types.
本発明で用いられる前記(A)成分のうち、しっとり感およびしっとり感の持続性を向上する観点からエンテロコッカス・フェカリス(Enterococcus faecalis)が好ましい。 Among the components (A) used in the present invention, Enterococcus faecalis is preferred from the viewpoint of improving the moist feeling and the sustainability of the moist feeling.
本発明で用いられる前記(A)成分の含有量は、好ましくは0.0001~2質量%、より好ましくは0.0005~1質量%、さらに好ましくは0.001~1質量%がよい。前記(A)成分が0.0001質量%未満の場合、しっとり感を付与できない恐れがある。前記(A)成分が1質量%を超える場合、それ以上のしっとり感の向上は認められない。 The content of the component (A) used in the present invention is preferably 0.0001 to 2% by mass, more preferably 0.0005 to 1% by mass, and still more preferably 0.001 to 1% by mass. When the amount of component (A) is less than 0.0001% by mass, there is a possibility that a moist feeling cannot be imparted. When the amount of component (A) exceeds 1% by mass, no further improvement in moist feeling is observed.
本発明はしっとり感およびしっとり感の持続性を付与する観点から(B)ラクトバチルス属(Lactobacillus)乳酸桿菌を含有する。 The present invention contains (B) Lactobacillus lactobacillus from the viewpoint of imparting a moist feeling and the sustainability of the moist feeling.
本発明の前記(B)成分はラクトバチルス属(Lactobacillus)乳酸桿菌の死菌体である。 The component (B) of the present invention is a killed bacterial cell of Lactobacillus lactobacillus.
本発明で用いられる前記(B)成分としては、特に限定されないが、例えば、ラクトバチルス・クリスパタス(Lactobacillus crispatus)、ラクトバチルス・カゼイ(Lactobacillus casei)、ラクトバチルス・ファーメンタム(Lactobacillus fermentum)、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)、ラクトバチルス・ブレビス(Lactobacillus brevis)、ラクトバチルス・ラムノサス(Lactobacillus rhamnosus)等が挙げられ、前記(B)成分は1種以上を含有してよい。 The component (B) used in the present invention is not particularly limited, but includes, for example, Lactobacillus crispatus, Lactobacillus casei, Lactobacillus fermentum, Lactobacillus - Examples include Lactobacillus paracasei, Lactobacillus brevis, Lactobacillus rhamnosus, etc., and the component (B) may contain one or more types.
本発明で用いられる前記(B)成分のうち、しっとり感およびしっとり感の持続性を付与する観点からラクトバチルス・クリスパタス(Lactobacillus crispatus)が好ましい。 Among the components (B) used in the present invention, Lactobacillus crispatus is preferred from the viewpoint of imparting a moist feeling and the sustainability of the moist feeling.
本発明で用いられる前記(B)成分の含有量は、好ましくは0.0001~2質量%、より好ましくは0.0005~1質量%、さらに好ましくは0.001~1質量%がよい。前記(B)成分が0.0001質量%未満の場合、しっとり感を付与できない恐れがある。前記(B)成分が1質量%を超える場合、それ以上のしっとり感の向上は認められない。 The content of the component (B) used in the present invention is preferably 0.0001 to 2% by mass, more preferably 0.0005 to 1% by mass, and even more preferably 0.001 to 1% by mass. When the amount of component (B) is less than 0.0001% by mass, there is a possibility that a moist feeling cannot be imparted. When the amount of component (B) exceeds 1% by mass, no further improvement in moist feeling is observed.
本発明で用いられる前記(A)成分および前記(B)成分を含有することでしっとり感の持続性を向上させることができる。 By containing the component (A) and the component (B) used in the present invention, the sustainability of the moist feeling can be improved.
本発明で用いられる前記(A)成分および前記(B)成分の含有量は、好ましくは0.0002~2質量%、より好ましくは0.001~2質量%、さらに好ましくは0.002~2質量%がよい。 The content of the component (A) and the component (B) used in the present invention is preferably 0.0002 to 2% by mass, more preferably 0.001 to 2% by mass, and even more preferably 0.002 to 2% by mass. Mass% is good.
本発明はもっちり感を付与する観点から(C)アミノ酸誘導体を含有する。 The present invention contains (C) an amino acid derivative from the viewpoint of imparting a chewy feel.
本発明で用いられる前記(C)成分としては、特に限定されないが、例えば、1分子内にアラニン、アルギニン、アスパラギン、アスパラギン酸、システイン、グルタミン、グルタミン酸、グリシン、ヒスチジン、イソロイシン、ロイシン、リシン、メチオニン、フェニルアラニン、プロリン、セリン、トレオニン、トリプトファン、チロシンおよびバリン等から選ばれるアミノ酸1種以上を含有する化合物およびその塩が挙げられ、前記(C)成分は1種以上含有してよい。前記(C)成分は、もっちり感を付与する観点から、特に、アルギニン誘導体およびグリシン誘導体が好ましい。 The component (C) used in the present invention is not particularly limited, but includes, for example, alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, and methionine in one molecule. , phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, etc., and salts thereof, and may contain one or more of the component (C). As the component (C), arginine derivatives and glycine derivatives are particularly preferable from the viewpoint of imparting a chewy feel.
前記アルギニン誘導体としては、特に限定されないが、例えば、ジヒロドキシプロピルアルギニンHCl、ココイルアルギニンエチルピロリドンカルボン酸、ピロリドンカルボン酸アルギニン、アスパラギン酸アルギニン、アセチルアルギニン、アルギニンHCl、グルタミン酸アルギニン等が挙げられる。 The arginine derivatives are not particularly limited, but include, for example, dihydroxypropyl arginine HCl, cocoyl arginine ethylpyrrolidone carboxylic acid, arginine pyrrolidone carboxylate, arginine aspartate, acetyl arginine, arginine HCl, arginine glutamate, and the like.
前記グリシン誘導体としては、特に限定されないが、例えば、カプリロイルグリシン、トリメチルグリシン、グリシルグリシン、ココイルグリシントリエタノールアミン、ラウリルアミノプロピルグリシン、ラウロイルグリシントリエタノールアミン等が挙げられる。 Examples of the glycine derivative include, but are not limited to, capryloylglycine, trimethylglycine, glycylglycine, cocoylglycine triethanolamine, lauryl aminopropylglycine, lauroylglycine triethanolamine, and the like.
本発明で用いられる前記(C)成分のうち、もっちり感を向上させる観点からジヒドロキシプロピルアルギニンHClおよびカプリロイルグリシンの組み合わせが好ましい。 Among the components (C) used in the present invention, a combination of dihydroxypropyl arginine HCl and capryloylglycine is preferred from the viewpoint of improving the chewy feeling.
本発明で用いられる前記(C)成分の含有量は、好ましくは0.002~1質量%、より好ましくは0.02~1質量%がよい。前記(C)成分が0.002質量%未満の場合、もっちり感を付与できない恐れがある。前記(C)成分が1質量%を超える場合、べたつきが生じ、使用感を損なう恐れがある。 The content of the component (C) used in the present invention is preferably 0.002 to 1% by mass, more preferably 0.02 to 1% by mass. When the amount of the component (C) is less than 0.002% by mass, there is a possibility that a chewy feeling cannot be imparted. If the content of component (C) exceeds 1% by mass, stickiness may occur and the feeling of use may be impaired.
本発明による皮膚化粧料組成物は、塗布時の使用感の観点から、20℃の条件下で粘度が500~35,000mPa・sであることが好ましい。 The skin cosmetic composition according to the present invention preferably has a viscosity of 500 to 35,000 mPa·s at 20° C. from the viewpoint of feeling when applied.
本発明において粘度は、常法にて調製し、得られた皮膚化粧料組成物をサンプル瓶(食品140:第一硝子株式会社製)に120g充填し、ヘリカルスタンド付きB型粘度計(モデル;デジタル粘度計TVB-10M、東機産業株式会社製)を用いて、M4号ローターにて1分間、回転速度12rpm、20℃の条件下で測定する。 In the present invention, the viscosity is determined by preparing the skin cosmetic composition using a conventional method, filling 120 g of the obtained skin cosmetic composition into a sample bottle (Food 140, manufactured by Daiichi Glass Co., Ltd.), and using a B-type viscometer with a helical stand (model; Measurement is performed using a digital viscometer TVB-10M (manufactured by Toki Sangyo Co., Ltd.) under the conditions of a rotation speed of 12 rpm and 20° C. for 1 minute with a No. M4 rotor.
本発明による皮膚化粧料組成物は、安定性の観点から、20℃の条件下でpHが4~8であり、より好ましくは5~7であることが好ましい。 From the viewpoint of stability, the skin cosmetic composition according to the present invention preferably has a pH of 4 to 8, more preferably 5 to 7, at 20°C.
本発明においてpHは、常法にて調製し、得られた皮膚化粧料組成物をサンプル瓶(食品140:第一硝子株式会社製)に120g充填し、ガラス電極式水素イオン濃度指示計(F-71:堀場製作所製)にて20℃の条件下で原液のpHを測定する。 In the present invention, the pH is adjusted by a conventional method, and 120 g of the obtained skin cosmetic composition is filled into a sample bottle (Food 140, manufactured by Daiichi Glass Co., Ltd.), and a glass electrode type hydrogen ion concentration indicator (F -71: manufactured by Horiba, Ltd.) to measure the pH of the stock solution at 20°C.
本発明の皮膚化粧料組成物は前記必須成分の他に、通常の化粧料、医薬部外品、医薬品等に用いられる各種成分、例えば、他の界面活性剤、油性成分、保湿剤、増粘剤、キレート剤、薬効成分、蛋白誘導体、加水分解蛋白、安定化剤、酸化防止剤、植物性抽出物、生薬抽出物、ビタミン類、香料、防腐剤、色素、顔料、粉体、pH調整剤、紫外線吸収剤等から選ばれる少なくとも1種以上を効果を損なわない範囲で含有することができる。ただし、これら例示に限定されるものでない。 In addition to the above-mentioned essential ingredients, the skin cosmetic composition of the present invention contains various ingredients used in ordinary cosmetics, quasi-drugs, pharmaceuticals, etc., such as other surfactants, oily ingredients, humectants, and thickeners. agents, chelating agents, medicinal ingredients, protein derivatives, hydrolyzed proteins, stabilizers, antioxidants, botanical extracts, crude drug extracts, vitamins, fragrances, preservatives, dyes, pigments, powders, pH adjusters , ultraviolet absorbers, etc., may be contained within a range that does not impair the effect. However, the present invention is not limited to these examples.
以下に実施例を挙げて本発明をさらに詳細に説明するが、これらは本発明を何ら限定するものではない。 The present invention will be explained in more detail with reference to Examples below, but these are not intended to limit the present invention in any way.
本明細書に示す評価試験において、皮膚化粧料組成物に含まれる成分、およびその含有量を種々変更しながら実施した。各成分の含有量を示す単位は全て質量%であり、これを常法にて調製した。 In the evaluation test shown in this specification, the components contained in the skin cosmetic composition and their contents were variously changed. All units indicating the content of each component are mass %, and were prepared by a conventional method.
本明細書に示す評価試験方法において、「しっとり感」、「しっとり感の持続性」および「もっちり感」について下記の方法で評価した。 In the evaluation test method shown in this specification, "moist feeling", "duration of moist feeling", and "fluffy feeling" were evaluated by the following methods.
「しっとり感」
実施例および比較例で得られた皮膚化粧料組成物のしっとり感を専門のパネラー15名で評価試験を行った。評価試験は、20℃に温度調節された実施例および比較例の皮膚化粧料組成物2gを室温20℃湿度60%の条件下で顔面全体に均一に塗布し、塗布時にしっとり感を感じたか否かを官能にて評価した。
<評価基準>
5:15人中13人以上がしっとり感を感じた。
4:15人中10人以上12人以下がしっとり感を感じた。
3:15人中7人以上9人以下がしっとり感を感じた。
2:15人中4人以上6人以下がしっとり感を感じた。
1:15人中3人以下がしっとり感を感じた。
"Moist feeling"
A test was conducted to evaluate the moist feel of the skin cosmetic compositions obtained in Examples and Comparative Examples by 15 expert panelists. In the evaluation test, 2 g of the skin cosmetic compositions of Examples and Comparative Examples, whose temperature was adjusted to 20°C, were applied uniformly to the entire face at a room temperature of 20°C and a humidity of 60%, and whether or not a moist feeling was felt upon application. This was evaluated by sensory evaluation.
<Evaluation criteria>
5:15 out of 15 people, more than 13 people felt moisturized.
4:15 out of 10 or more and 12 or less people felt moisturized.
3:7 to 9 people out of 15 people felt moist.
2: Out of 15 people, 4 or more and 6 or less felt a moist feeling.
1:3 or less out of 15 people felt moist.
「しっとり感の持続性」
実施例および比較例で得られた皮膚化粧料組成物のしっとり感の持続性を専門のパネラー15名で評価試験を行った。評価試験は、20℃に温度調節された実施例および比較例の皮膚化粧料組成物2gを室温20℃湿度60%の条件下で顔面全体に均一に塗布し、そのまま6時間皮膚に触れずに待機した後にしっとり感を感じたか否かを官能にて評価した。
<評価基準>
5:15人中13人以上が「しっとり感」で評価した結果と比較し、同程度のしっとり感を感じた。
4:15人中10人以上12人以下が「しっとり感」で評価した結果と比較し、同程度のしっとり感を感じた。
3:15人中7人以上9人以下が「しっとり感」で評価した結果と比較し、同程度のしっとり感を感じた。
2:15人中4人以上6人以下が「しっとり感」で評価した結果と比較し、同程度のしっとり感を感じた。
1:15人中3人以下が「しっとり感」で評価した結果と比較し、同程度のしっとり感を感じた。
"Sustainable moist feeling"
An evaluation test was conducted by 15 expert panelists to evaluate the durability of the moist feeling of the skin cosmetic compositions obtained in the Examples and Comparative Examples. In the evaluation test, 2 g of the skin cosmetic compositions of the Examples and Comparative Examples, whose temperature was adjusted to 20°C, were applied uniformly to the entire face at a room temperature of 20°C and a humidity of 60%, and the skin was left untouched for 6 hours. After waiting, a sensory evaluation was made to determine whether a moist feeling was felt.
<Evaluation criteria>
5: More than 13 out of 15 people felt the same level of moistness compared to the results evaluated for "moist feeling".
4: 10 to 12 out of 15 people felt the same level of moistness compared to the results evaluated in terms of "moist feeling".
3: 7 or more and 9 or less out of 15 people felt the same level of moistness compared to the "moist feeling" evaluation results.
2: More than 4 people and less than 6 people out of 15 people felt the same level of moistness compared to the results evaluated by "moist feeling".
1: Less than 3 out of 15 people felt the same level of moistness compared to the evaluation results for "moist feeling".
「もっちり感」
実施例および比較例で得られた皮膚化粧料組成物のもっちり感を専門のパネラー15名で評価試験を行った。評価試験は、20℃に温度調節された実施例および比較例の皮膚化粧料組成物2gを室温20℃湿度60%の条件下で顔面全体に均一に塗布し、塗布時にもっちり感を感じたか否かを官能にて評価した。
<評価基準>
5:15人中13人以上がもっちり感を感じた。
4:15人中10人以上12人以下がもっちり感を感じた。
3:15人中7人以上9人以下がもっちり感を感じた。
2:15人中4人以上6人以下がもっちり感を感じた。
1:15人中3人以下がもっちり感を感じた。
"A chewy feeling"
A test was conducted to evaluate the elasticity of the skin cosmetic compositions obtained in Examples and Comparative Examples by 15 expert panelists. In the evaluation test, 2 g of the skin cosmetic compositions of the Examples and Comparative Examples, whose temperature was adjusted to 20°C, were applied uniformly to the entire face at a room temperature of 20°C and a humidity of 60%, and whether the skin felt firm when applied. A sensory evaluation was made to determine whether or not the product was present.
<Evaluation criteria>
5:15 out of 15 people, more than 13 people felt a feeling of elasticity.
4:15 out of 10 or more and 12 or less felt the feeling of being sticky.
3: More than 7 people and less than 9 people out of 15 people felt a feeling of elasticity.
2: Out of 15 people, 4 or more and 6 or less felt a feeling of elasticity.
1: Less than 3 out of 15 people felt a sticky feeling.
※1:ラ・フローラ EC-12(一丸ファルコス社製)
※2:KT-11 HKN(キティー社製)
※3:Amitose R(成和化成社製)
※4:LIPACIDE C8G(SEPPIC S.A.社製)
※5:Enterococcus faecium(セティ社製)
※6:Lactobacillus casei(セティ社製)
※7:CAE(味の素社製)
※8:アミノコート(旭化成ファインケム社製)
*1: La Flora EC-12 (manufactured by Ichimaru Falcos)
*2: KT-11 HKN (manufactured by Kitty)
*3: Amitose R (manufactured by Seiwa Kasei Co., Ltd.)
*4: LIPACIDE C8G (manufactured by SEPPIC S.A.)
*5: Enterococcus faecium (manufactured by Seti)
*6: Lactobacillus casei (manufactured by Seti)
*7: CAE (manufactured by Ajinomoto Co.)
*8: Amino coat (manufactured by Asahi Kasei Finechem)
表1~表4に示す実施例1~30から、皮膚に対してしっとり感およびもっちり感を付与し、しっとり感の持続性が良好な皮膚化粧料組成物について良好な結果を得ることが確認された。 From Examples 1 to 30 shown in Tables 1 to 4, it was confirmed that good results were obtained for skin cosmetic compositions that imparted a moist and elastic feel to the skin and had good sustainability of the moist feeling. It was done.
以下、実施例31~34を使用して評価試験を行っても、皮膚に対してしっとり感およびもっちり感を付与し、しっとり感の持続性が良好な皮膚化粧料組成物が得られた。 Even when evaluation tests were conducted using Examples 31 to 34 below, skin cosmetic compositions that imparted a moist and elastic feel to the skin and had good long-lasting moist feeling were obtained.
<実施例31(化粧水)>
成 分 含有量(質量%)
(A)エンテロコッカス・フェカリス
(Enterococcus faecalis) 0.010
(B)ラクトバチルス・クリスパタス
(Lactobacillus crispatus) 0.002
(C)ジヒドロキシプロピルアルギニンHCl 0.030
(C)カプリロイルグリシン 0.050
エデト酸ニナトリウム 0.050
カルボキシメチルセルロースナトリウム 0.050
アクリル酸・メタクリル酸アルキル共重合体 0.200
ヒアルロン酸ナトリウム(2) 0.010
1,3-ブチレングリコール 9.000
ヒドロキシエチルセルロース 0.050
ジプロピレングリコール 5.000
濃グリセリン 4.000
ポリオキシエチレンメチルグルコシド 2.000
フェノキシエタノール 0.300
グリセリンモノ2-エチルヘキシルエーテル 0.200
2-アミノ-2-メチル-1-プロパノール 0.080
N-ラウロイル-L-グルタミン酸
ジ(フィトステリル・2-オクチルドデシル) 0.150
ポリスチレン 0.098
サクシニルアテロコラーゲン 0.010
デキストリン 0.008
香料 0.012
精製水 78.690
合計 100.000
<Example 31 (lotion)>
Component Content (mass%)
(A) Enterococcus faecalis
(Enterococcus faecalis) 0.010
(B) Lactobacillus crispatus
(Lactobacillus crispatus) 0.002
(C) Dihydroxypropyl arginine HCl 0.030
(C) Capryloylglycine 0.050
Edetate disodium 0.050
Carboxymethyl cellulose sodium 0.050
Acrylic acid/alkyl methacrylate copolymer 0.200
Sodium hyaluronate (2) 0.010
1,3-butylene glycol 9.000
Hydroxyethyl cellulose 0.050
Dipropylene glycol 5.000
Concentrated glycerin 4.000
Polyoxyethylene methyl glucoside 2.000
Phenoxyethanol 0.300
Glycerin mono-2-ethylhexyl ether 0.200
2-amino-2-methyl-1-propanol 0.080
N-lauroyl-L-glutamate di(phytosteryl 2-octyldodecyl) 0.150
Polystyrene 0.098
Succinyl atelocollagen 0.010
Dextrin 0.008
Fragrance 0.012
Purified water 78.690
Total 100.000
<実施例32(乳液)>
成 分 含有量(質量%)
(A)エンテロコッカス・フェカリス
(Enterococcus faecalis) 0.010
(B)ラクトバチルス・クリスパタス
(Lactobacillus crispatus) 0.002
(C)ジヒドロキシプロピルアルギニンHCl 0.030
(C)カプリロイルグリシン 0.050
ミリスチン酸イソプロピル 7.500
ワセリン 0.500
モノイソステアリン酸ソルビタン 0.500
エデト酸ニナトリウム 0.110
アクリル酸・メタクリル酸アルキル共重合体 0.230
濃グリセリン 3.000
1,3-ブチレングリコール 7.000
フェノキシエタノール 0.300
グリセリンモノ2-エチルヘキシルエーテル 0.200
ポリオキシエチレンメチルグルコシド 2.000
ヒドロキシエチルセルロース 0.300
ヒアルロン酸ナトリウム(2) 0.010
2-アミノ-2-メチル-1-プロパノール 0.120
サクシニルアテロコラーゲン 0.100
デキストリン 0.008
香料 0.016
精製水 78.014
合計 100.000
<Example 32 (emulsion)>
Component Content (mass%)
(A) Enterococcus faecalis
(Enterococcus faecalis) 0.010
(B) Lactobacillus crispatus
(Lactobacillus crispatus) 0.002
(C) Dihydroxypropyl arginine HCl 0.030
(C) Capryloylglycine 0.050
Isopropyl myristate 7.500
Vaseline 0.500
Sorbitan monoisostearate 0.500
Edetate disodium 0.110
Acrylic acid/alkyl methacrylate copolymer 0.230
Concentrated glycerin 3.000
1,3-butylene glycol 7.000
Phenoxyethanol 0.300
Glycerin mono-2-ethylhexyl ether 0.200
Polyoxyethylene methyl glucoside 2.000
Hydroxyethyl cellulose 0.300
Sodium hyaluronate (2) 0.010
2-amino-2-methyl-1-propanol 0.120
Succinyl atelocollagen 0.100
Dextrin 0.008
Fragrance 0.016
Purified water 78.014
Total 100.000
<実施例33(クリーム)>
成 分 含有量(質量%)
(A)エンテロコッカス・フェカリス
(Enterococcus faecalis) 0.010
(B)ラクトバチルス・クリスパタス
(Lactobacillus crispatus) 0.002
(C)ジヒドロキシプロピルアルギニンHCl 0.030
(C)カプリロイルグリシン 0.050
濃グリセリン 3.000
1,3-ブチレングリコール 7.000
パラオキシ安息香酸メチル 0.300
ポリオキシエチレンメチルグルコシド 2.000
エデト酸ニナトリウム 0.050
アクリル酸・メタクリル酸アルキル共重合体 0.200
(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー 0.500
ミリスチン酸オクチルドデシル 5.000
スクワラン 5.600
モノステアリン酸ソルビタン 0.400
ステアリン酸ステアリル 0.300
2-アミノ-2-メチル-1-プロパノール 0.200
ヒアルロン酸ナトリウム(2) 0.010
サクシニルアテロコラーゲン 0.100
デキストリン 0.008
香料 0.016
精製水 75.224
合計 100.000
<Example 33 (cream)>
Component Content (mass%)
(A) Enterococcus faecalis
(Enterococcus faecalis) 0.010
(B) Lactobacillus crispatus
(Lactobacillus crispatus) 0.002
(C) Dihydroxypropyl arginine HCl 0.030
(C) Capryloylglycine 0.050
Concentrated glycerin 3.000
1,3-butylene glycol 7.000
Methyl paraoxybenzoate 0.300
Polyoxyethylene methyl glucoside 2.000
Edetate disodium 0.050
Acrylic acid/alkyl methacrylate copolymer 0.200
(Acryloyldimethyltaurine ammonium/VP) copolymer 0.500
Octyldodecyl myristate 5.000
Squalane 5.600
Sorbitan monostearate 0.400
Stearyl stearate 0.300
2-Amino-2-methyl-1-propanol 0.200
Sodium hyaluronate (2) 0.010
Succinyl atelocollagen 0.100
Dextrin 0.008
Fragrance 0.016
Purified water 75.224
Total 100.000
<実施例34(パック)>
成 分 含有量(質量%)
(A)エンテロコッカス・フェカリス
(Enterococcus faecalis) 0.010
(B)ラクトバチルス・クリスパタス
(Lactobacillus crispatus) 0.002
(C)ジヒドロキシプロピルアルギニンHCl 0.030
(C)カプリロイルグリシン 0.050
エデト酸ニナトリウム 0.100
濃グリセリン 5.000
ジプロピレングリコール 4.000
1,3-ブチレングリコール 12.000
フェノキシエタノール 0.300
アクリル酸・メタクリル酸アルキル共重合体 0.250
ビスステアリルPEG/PPG-8/6
(SMDI/PEG-400)コポリマー 1.100
ヒドロキシエチルセルロース 0.300
ヒアルロン酸ナトリウム(2) 0.010
グリセリンモノ2-エチルヘキシルエーテル 0.200
メチルポリシロキサン 1.800
N-ラウロイル-L-グルタミン酸
ジ(フィトステリル・2-オクチルドデシル) 0.300
モノステアリン酸ポリオキシエチレンソルビタン 0.100
2-アミノ-2-メチル-1-プロパノール 0.090
サクシニルアテロコラーゲン 0.100
デキストリン 0.008
香料 0.016
精製水 74.234
合計 100.000
<Example 34 (pack)>
Component Content (mass%)
(A) Enterococcus faecalis
(Enterococcus faecalis) 0.010
(B) Lactobacillus crispatus
(Lactobacillus crispatus) 0.002
(C) Dihydroxypropyl arginine HCl 0.030
(C) Capryloylglycine 0.050
Edetate disodium 0.100
Concentrated glycerin 5.000
Dipropylene glycol 4.000
1,3-butylene glycol 12.000
Phenoxyethanol 0.300
Acrylic acid/alkyl methacrylate copolymer 0.250
Bisstearyl PEG/PPG-8/6
(SMDI/PEG-400) copolymer 1.100
Hydroxyethyl cellulose 0.300
Sodium hyaluronate (2) 0.010
Glycerin mono-2-ethylhexyl ether 0.200
Methyl polysiloxane 1.800
N-lauroyl-L-glutamic acid di(phytosteryl 2-octyldodecyl) 0.300
Polyoxyethylene sorbitan monostearate 0.100
2-Amino-2-methyl-1-propanol 0.090
Succinyl atelocollagen 0.100
Dextrin 0.008
Fragrance 0.016
Purified water 74.234
Total 100.000
本発明は、皮膚に対してしっとり感およびもっちり感を付与し、しっとり感の持続性が良好な皮膚化粧料組成物を得ることができる。 INDUSTRIAL APPLICABILITY The present invention can provide a skin cosmetic composition that imparts a moist and elastic feel to the skin and has a good long-lasting moist feeling.
Claims (1)
(B)ラクトバチルス・クリスパタス(Lactobacillus crispatus)
(C)ジヒドロキシプロピルアルギニンHClおよびカプリロイルグリシン
を含有し、前記(A)成分の含有量が0.001~1質量%、前記(B)成分の含有量が0.001~1質量%、前記(C)成分の含有量が0.02~1質量%である皮膚化粧料組成物。
(A) Enterococcus faecalis
(B) Lactobacillus crispatus
(C) Dihydroxypropyl arginine HCl and capryloylglycine
The content of the component (A) is 0.001 to 1% by mass, the content of the component (B) is 0.001 to 1% by mass, and the content of the component ( C) is 0.02% by mass. ~1% by mass of a skin cosmetic composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019236476A JP7377526B2 (en) | 2019-12-26 | 2019-12-26 | Skin cosmetic composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019236476A JP7377526B2 (en) | 2019-12-26 | 2019-12-26 | Skin cosmetic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021104966A JP2021104966A (en) | 2021-07-26 |
| JP7377526B2 true JP7377526B2 (en) | 2023-11-10 |
Family
ID=76918578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019236476A Active JP7377526B2 (en) | 2019-12-26 | 2019-12-26 | Skin cosmetic composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7377526B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024048485A (en) * | 2022-09-28 | 2024-04-09 | 株式会社成和化成 | Cosmetics containing arginine derivatives |
| JP2024124070A (en) * | 2023-03-02 | 2024-09-12 | 株式会社みらい中央研究所 | Emulsion composition, cosmetic composition containing same, and method for producing emulsion composition |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004269408A (en) | 2003-03-07 | 2004-09-30 | Aureo Co Ltd | Humectant for skin |
| JP2010173991A (en) | 2009-01-30 | 2010-08-12 | Kouai Kagaku Co Ltd | External preparation for skin |
| JP2015040201A (en) | 2013-08-23 | 2015-03-02 | 株式会社キティー | Composition for cosmetics |
| JP2015157773A (en) | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | cosmetic |
| JP2019001723A (en) | 2017-06-12 | 2019-01-10 | 株式会社ナリス化粧品 | Cosmetic composition |
| JP2021042172A (en) | 2019-09-12 | 2021-03-18 | 株式会社アノワ | Composition for application to female dz |
-
2019
- 2019-12-26 JP JP2019236476A patent/JP7377526B2/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004269408A (en) | 2003-03-07 | 2004-09-30 | Aureo Co Ltd | Humectant for skin |
| JP2010173991A (en) | 2009-01-30 | 2010-08-12 | Kouai Kagaku Co Ltd | External preparation for skin |
| JP2015040201A (en) | 2013-08-23 | 2015-03-02 | 株式会社キティー | Composition for cosmetics |
| JP2015157773A (en) | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | cosmetic |
| JP2019001723A (en) | 2017-06-12 | 2019-01-10 | 株式会社ナリス化粧品 | Cosmetic composition |
| JP2021042172A (en) | 2019-09-12 | 2021-03-18 | 株式会社アノワ | Composition for application to female dz |
Non-Patent Citations (2)
| Title |
|---|
| Aqua-Collagen-Gel Aloe Cool Moisturiser, ID# 6670113,Mintel GNPD [online],2019年06月,[検索日2023.07.19], <URL:http://www.gnpd.com> |
| Perfect Agest-DX Skin-Defense Formula, ID# 1972794,Mintel GNPD [online],2012年10月,[検索日2023.07.19], <URL:http://www.gnpd.com> |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021104966A (en) | 2021-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7812522B2 (en) | Cosmetics | |
| JP6912772B2 (en) | Hyaluronic acid production promoter and cosmetics containing it | |
| CN101111289B (en) | Anti-aging cosmetic composition | |
| JP5334511B2 (en) | Cosmetics | |
| CN116847871A (en) | Skin care compositions and methods of use | |
| JP2005330257A (en) | Cosmetic | |
| JP6802711B2 (en) | Moisturizing base material containing a lipid peptide type compound | |
| JP2013067594A (en) | Cosmetic containing prunus persica gum | |
| WO2020095425A1 (en) | Cosmetic | |
| JPWO2020004649A1 (en) | Film-forming composition | |
| JP2021161034A (en) | Skin flora balance improver | |
| JP2010265189A (en) | Antibacterial cosmetics | |
| JP5247131B2 (en) | Egg white hydrolyzate, method for producing the same, and cosmetics | |
| JP6639816B2 (en) | Cosmetics | |
| JP7377526B2 (en) | Skin cosmetic composition | |
| CN107530260B (en) | Skin external preparation | |
| JP2021080210A (en) | Oil-based cosmetics | |
| JP2018070532A (en) | Preadipocyte differentiation-promoting agent | |
| JP2005255535A (en) | Pretreatment agent for hair dyeing | |
| JP6029973B2 (en) | Skin cleanser composition | |
| JP7544514B2 (en) | Cosmetics or skin preparations containing inulin and polyhydric alcohol | |
| JP2008308462A (en) | Skin external composition | |
| JP7570677B2 (en) | Skin cosmetics | |
| JP2017109927A (en) | Amino acid formulated facial skin external preparation | |
| JPWO2019139143A1 (en) | Composition containing powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220909 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230720 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230801 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230919 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231017 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231023 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7377526 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |